SC golimumab

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	36

46. 悪性関節リウマチ

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

trials per page:

Showing 1 to 10 of 36 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02728934 (ClinicalTrials.gov)	February 25, 2016	31/3/2016	Comparative and Pragmatic Study of GolimumabIntravenous (IV) (Simponi Aria) Versus Infliximab (Remic ...	Comparative and Pragmatic Study of Simponi Aria Versus Remicade in Rheumatoid Arthritis	Arthritis, Rheumatoid	Biological: Golimumab Intravenous (IV);Biological: Infliximab;Biological: Biosimilar Infliximab	Janssen Scientific Affairs, LLC	NULL	Completed	18 Years	N/A	All	1279		United States
2	JPRN-UMIN000011891	2013/10/01	01/10/2013	Multicenter study of the effect of GoLimumabOn the Remission Induction rate and bio-free remission m ...	Multicenter study of the effect of GoLimumabOn the Remission Induction rate and bio-free remission m ...	Rheumatoid Arthritis	Golimumab	St.Marianna University School of Medicine	NULL	Complete: follow-up complete	20years-old	70years-old	Male and Female	50	Not selected	Japan
3	JPRN-UMIN000014485	2013/05/24	01/12/2014	Golimumab study for development of tight control and biologics-free condition.	Golimumab study for development of tight control and biologics-free condition. - Go-sunrising study	rheumatoid arthritis	Treatment with Golimumab for patients with rheumatoid arthritis	Rheumatology, Internal MedicineJuntendo University School of Medicine, Juntendo Koshigaya Hospital	NULL	Complete: follow-up complete	20years-old	Not applicable	Male and Female	40	Not selected	Japan
4	JPRN-UMIN000009425	2012/12/06	01/12/2012	A validity inspection study of the treat-to-target strategy with golimumabfor the treatment of rheum ...	A validity inspection study of the treat-to-target strategy with golimumabfor the treatment of rheum ...	Rheumatoid Arthritis	The dose of golimumabshould be fixed as 50 mg/month for all period. Treat-to-target strategy might b ...	Osaka City University Medical School	NULL	Recruiting	20years-old	Not applicable	Male and Female	150	Phase 4	Japan
5	EUCTR2011-000311-34-IT (EUCTR)	03/02/2012	06/12/2011	GO-AHEAD	A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Effect of GolimumabAdminist ...	Active Axial Spondyloarthritis (SpA) MedDRA version: 14.0;Level: HLT;Classification code 10039075;Te ...	Trade Name: Simponi INN or Proposed INN: GOLIMUMAB	SCHERING PLOUGH RESEARCH INSTITUTE, A DIVISION OF SCHERING CORPORATION	NULL	Not Recruiting			Female: yes Male: yes	200	Phase 3	United States;Greece;Canada;Finland;Spain;Turkey;Russian Federation;Germany;United Kingdom;Italy
6	EUCTR2010-021020-94-HU (EUCTR)	08/04/2011	05/10/2010	A randomized, double-blind, parallel-group, placebo- and active calibrator-controlledstudy assessing ...	A randomized, double-blind, parallel-group, placebo- and active calibrator-controlledstudy assessing ...	active rheumatoid arthritis MedDRA version: 12.1;Level: PT;Classification code 10039073;Term: Rheuma ...	Product Name: SAR153191 Product Code: SAR153191 Trade Name: Simponi INN or Proposed INN: GOLIMUMAB	Sanofi-aventis Recherche & Développement	NULL	Not Recruiting			Female: yes Male: yes	250		Hungary;Czech Republic;Germany;Spain;Italy
7	EUCTR2010-021020-94-DE (EUCTR)	10/03/2011	15/09/2010	A randomized, double-blind, parallel-group, placebo- and active calibrator-controlledstudy assessing ...	A randomized, double-blind, parallel-group, placebo- and active calibrator-controlledstudy assessing ...	active rheumatoid arthritis MedDRA version: 13.1;Level: PT;Classification code 10039073;Term: Rheuma ...	Product Code: SAR153191 Trade Name: Simponi INN or Proposed INN: GOLIMUMAB	Sanofi-aventis Recherche & Développement	NULL	Not Recruiting			Female: yes Male: yes	250		Hungary;Czech Republic;Germany;Spain;Italy
8	EUCTR2010-021020-94-ES (EUCTR)	21/12/2010	21/10/2010	Estudio aleatorizado, doble ciego, con grupos paralelos, controlado con placebo y control activo par ...	Estudio aleatorizado, doble ciego, con grupos paralelos, controlado con placebo y control activo par ...	artritis reumatoide activa MedDRA version: 12.1;Level: PT;Classification code 10039073;Term: Rheumat ...	Product Code: SAR153191 Trade Name: SIMPONI 50 mg solución inyectable en pluma precargada INN or Propo ...	Sanofi-aventis Recherche & Développement	NULL	Not Recruiting			Female: yes Male: yes	250		Hungary;Czech Republic;Germany;Spain;Italy
9	EUCTR2010-021020-94-CZ (EUCTR)	17/12/2010	05/10/2010	A randomized, double-blind, parallel-group, placebo- and active calibrator-controlledstudy assessing ...	A randomized, double-blind, parallel-group, placebo- and active calibrator-controlledstudy assessing ...	active rheumatoid arthritis MedDRA version: 13.1;Level: PT;Classification code 10039073;Term: Rheuma ...	Product Code: SAR153191 Trade Name: Simponi INN or Proposed INN: GOLIMUMAB	Sanofi-aventis Recherche & Développement	NULL	Not Recruiting			Female: yes Male: yes	250		Hungary;Germany;Czech Republic;Spain;Italy
10	NCT01217814 (ClinicalTrials.gov)	November 2010	7/10/2010	Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Fail ...	A Randomized, Double-blind, Parallel-group, Placebo- and Active Calibrator-controlled Study Assessin ...	Rheumatoid Arthritis	Drug: Sarilumab;Drug: Placebo;Drug: Golimumab;Drug: methotrexate (MTX);Drug: Folic/folinic acid	Sanofi	Regeneron Pharmaceuticals	Terminated	18 Years	75 Years	All	16	Phase 2	United States;Colombia;Czechia;Italy;Mexico;Spain;Brazil;Canada;Czech Republic;Germany;Hungary;Norwa ...

First Previous1 2 3 4Next Last